Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Neumologia | EligiMed
Ensayos clinicos
898 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of ASA404 in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00662597
Completado
ClinicalTrials.gov
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina
OBSERVATIONAL
Inicio: 10 de jun de 2020
ID: NCT04472078
Terminado
Fase 3
ClinicalTrials.gov
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
INTERVENTIONAL
Inicio: 30 de sept de 2020
ID: NCT04419558
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Parallel-group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients Comparing Rivaroxaban With Enoxaparin. The MAGELLAN Study
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00571649
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Controlled, Open Label, Two Arms, Exploratory Study to Evaluate the Effect of Everolimus on Histologically Assessed Fibrosis Progression (Ishak-Knodell) in Liver Transplant Recipients With Recurrent Hepatitis C Viral Infection as Compared to Standard Treatment.
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00582738
Activo, no recluta
ClinicalTrials.gov
OptimAIR: Towards Right Care in Asthma Through Point-of-care Phenotyping, Guideline-based Assessment and Management Optimalisation Using the AsthmaOptimiser in Primary Care
INTERVENTIONAL
Inicio: 1 de may de 2025
ID: NCT07390669
Completado
Fase 2
ClinicalTrials.gov
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Six Week Study Of The Efficacy And Safety Of Tofimilast Dry Powder For Inhalation In Adults Diagnosed With Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 1 de may de 2004
ID: NCT00219622
Completado
Fase 3
ClinicalTrials.gov
A 24 Week, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Roflumilast (250 mcg or 500 mcg) Daily in Patients With Asthma
INTERVENTIONAL
Inicio: 1 de nov de 2003
ID: NCT00073177
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants Whose Disease Has Remained Stable or Responded to First-Line Platinum -Based Chemotherapy With Pembrolizumab for Stage IIIB/IIIC or IV Non-Small Cell Lung Cancer (ZEAL-1L)
INTERVENTIONAL
Inicio: 26 de oct de 2020
ID: NCT04475939
Completado
Fase 3
ClinicalTrials.gov
A Phase III Open-Label, Multicenter Trial of Avelumab (MSB0010718C) Versus Docetaxel in Subjects With Non-Small Cell Lung Cancer That Has Progressed After a Platinum-Containing Doublet
INTERVENTIONAL
Inicio: 24 de mar de 2015
ID: NCT02395172
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Open Label Study Comparing Safety and Efficacy Parameters for a High and a Low Dose of Ambrisentan (Adjusted for Body Weight) for the Treatment of Pulmonary Arterial Hypertension in Paediatric Patients Aged 8 Years up to 18 Years
INTERVENTIONAL
Inicio: 4 de ene de 2011
ID: NCT01332331
Completado
Fase 1
ClinicalTrials.gov
A Phase 1 Study of BMS-986416 Alone and in Combination With Nivolumab in Select Solid Tumors
INTERVENTIONAL
Inicio: 9 de ago de 2021
ID: NCT04943900
Completado
Fase 3
ClinicalTrials.gov
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)
INTERVENTIONAL
Inicio: 6 de oct de 2022
ID: NCT05321069
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
INTERVENTIONAL
Inicio: 11 de jun de 2015
ID: NCT02414139
Completado
ClinicalTrials.gov
Asynchrony During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome
OBSERVATIONAL
Inicio: 25 de may de 2016
ID: NCT02732041
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00076388
Completado
ClinicalTrials.gov
Asthmatic Subjects Could Live Without Short Acting Beta2 Agonists (SABA)
OBSERVATIONAL
Inicio: 10 de mar de 2017
ID: NCT03498742
Completado
Fase 3
ClinicalTrials.gov
A 26-week Treatment Randomized, Double-blind, Double Dummy, Parallel-group Study to Assess the Efficacy and Safety of QVA149 (Indacaterol / Glycopyrronium Bromide) Compared to Fluticasone/Salmeterol in Patients With Moderate to Severe COPD
INTERVENTIONAL
Inicio: 1 de nov de 2012
ID: NCT01709903
Anterior
1
...
44
45
Filtros